The Latest in AML

Team targets transcription factor in AML

March 9, 2018

HSCT approach provides ‘excellent’ survival in FA

March 2, 2018

CHMP recommends approval for GO in AML

March 1, 2018

Expanded UCB product can stand alone

February 27, 2018

FDA grants ivosidenib NDA priority review

February 17, 2018

NK-cell therapy in resistant MDS, AML

February 16, 2018

Azacitidine now available in China

February 9, 2018

EC grants orphan designation to gilteritinib for AML

January 24, 2018

FDA expands approval for arsenic trioxide

January 16, 2018

EMA recommends orphan designation for pracinostat

January 12, 2018

Survival differences among AYAs with blood cancers

January 11, 2018

Marine animals aid development of cytotoxicity assay

January 11, 2018

Team finds way to target MYB in AML

January 9, 2018

CX-01 receives orphan designation for AML

January 4, 2018

FDA lifts hold on trial of SEL24 in AML

January 3, 2018